Login / Signup

Defying the Odds: 30 Years in AL Amyloidosis Research, Recent Barriers to Clinical Trial Enrollment.

Vaishali SanchorawalaBruna BarrosoAnthony C SheltonElise GoetzLisa MendelsonTracy JoshiNatasha J BurkeJ Mark SloanAndrew Staron
Published in: Blood advances (2024)
Keyphrases
  • clinical trial
  • health insurance
  • phase ii
  • double blind
  • open label
  • multiple myeloma
  • study protocol
  • phase iii
  • affordable care act
  • randomized controlled trial
  • healthcare
  • placebo controlled